Literature DB >> 21900377

Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1.

Mark E Pennesi1, Niamh B Stover, Edwin M Stone, Pei-Wen Chiang, Richard G Weleber.   

Abstract

PURPOSE: To describe in detail the clinical phenotype and electrophysiological features of three patients with Leber congenital amaurosis caused by mutations of AIPL1.
METHODS: Ophthalmologic examination, color fundus photography, detailed electrophysiological assessment, and screening of AIPL1 were undertaken in three subjects. One patient also underwent visual field testing and spectral domain-optical coherence tomography.
RESULTS: All three patients, two of whom were siblings, had histories consistent with Leber congenital amaurosis (severely reduced vision, poorly responsive pupils, and nystagmus presenting within the first year of life). However, each patient had recordable and similar electroretinograms (ERGs), which demonstrated absent cone-driven responses and slow insensitive scotopic responses. The first patient was found to have a homozygous Trp278 stop mutation in AIPL1, whereas the siblings were each found to have novel heterozygous mutations in AIPL1 (Leu17Pro and Lys214Asn).
CONCLUSIONS: Patients with mutations in AIPL1 may present with Leber congenital amaurosis and residual ERGs characterized by slow insensitive scotopic responses. Such responses are likely seen only in very young patients and may not be seen with the typical filter settings recommended by the ISCEV standards because of low-pass filtering. Progressive loss of residual ERG activity in young LCA patients with AIPL1 mutations suggests that gene replacement therapy will likely have to be performed early.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900377      PMCID: PMC3208025          DOI: 10.1167/iovs.11-8298

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  Mutations in a new photoreceptor-pineal gene on 17p cause Leber congenital amaurosis.

Authors:  M M Sohocki; S J Bowne; L S Sullivan; S Blackshaw; C L Cepko; A M Payne; S S Bhattacharya; S Khaliq; S Qasim Mehdi; D G Birch; W R Harrison; F F Elder; J R Heckenlively; S P Daiger
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

2.  The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1.

Authors:  Dayna T Akey; Xuemei Zhu; Michael Dyer; Aimin Li; Adam Sorensen; Seth Blackshaw; Taeko Fukuda-Kamitani; Stephen P Daiger; Cheryl M Craft; Tetsu Kamitani; Melanie M Sohocki
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

Review 3.  Unfolding retinal dystrophies: a role for molecular chaperones?

Authors:  J P Chapple; C Grayson; A J Hardcastle; R S Saliba; J van der Spuy; M E Cheetham
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

4.  The Leber congenital amaurosis gene product AIPL1 is localized exclusively in rod photoreceptors of the adult human retina.

Authors:  Jacqueline van der Spuy; J Paul Chapple; Brian J Clark; Philip J Luthert; Charanjit S Sethi; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

5.  Evaluation of Italian patients with leber congenital amaurosis due to AIPL1 mutations highlights the potential applicability of gene therapy.

Authors:  Francesco Testa; Enrico Maria Surace; Settimio Rossi; Elena Marrocco; Annagiusi Gargiulo; Valentina Di Iorio; Carmela Ziviello; Anna Nesti; Simona Fecarotta; Maria Laura Bacci; Massimo Giunti; Michele Della Corte; Sandro Banfi; Alberto Auricchio; Francesca Simonelli
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

6.  AIPL1, a protein implicated in Leber's congenital amaurosis, interacts with and aids in processing of farnesylated proteins.

Authors:  Visvanathan Ramamurthy; Melanie Roberts; Focco van den Akker; Gregory Niemi; T A Reh; James B Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

7.  The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations.

Authors:  Sharola Dharmaraj; Bart P Leroy; Melanie M Sohocki; Robert K Koenekoop; Isabelle Perrault; Khalid Anwar; Shagufta Khaliq; R Summathi Devi; David G Birch; Elaine De Pool; Natalio Izquierdo; Lionel Van Maldergem; Mohammad Ismail; Annette M Payne; Graham E Holder; Shomi S Bhattacharya; Alan C Bird; Josseline Kaplan; Irene H Maumenee
Journal:  Arch Ophthalmol       Date:  2004-07

8.  The expression of the Leber congenital amaurosis protein AIPL1 coincides with rod and cone photoreceptor development.

Authors:  Jacqueline van der Spuy; Jeong H Kim; Young S Yu; Agoston Szel; Philip J Luthert; Brian J Clark; Michael E Cheetham
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-12       Impact factor: 4.799

9.  AIPL1, the protein that is defective in Leber congenital amaurosis, is essential for the biosynthesis of retinal rod cGMP phosphodiesterase.

Authors:  Xiaoqing Liu; Oleg V Bulgakov; Xiao-Hong Wen; Michael L Woodruff; Basil Pawlyk; Jun Yang; Gordon L Fain; Michael A Sandberg; Clint L Makino; Tiansen Li
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

10.  Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis.

Authors:  Sylvain Hanein; Isabelle Perrault; Sylvie Gerber; Gaëlle Tanguy; Fabienne Barbet; Dominique Ducroq; Patrick Calvas; Hélène Dollfus; Christian Hamel; Tuija Lopponen; Francis Munier; Louisa Santos; Stavit Shalev; Dimitrios Zafeiriou; Jean-Louis Dufier; Arnold Munnich; Jean-Michel Rozet; Josseline Kaplan
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

View more
  14 in total

Review 1.  Gene therapy for Leber congenital amaurosis: advances and future directions.

Authors:  Robert B Hufnagel; Zubair M Ahmed; Zélia M Corrêa; Robert A Sisk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-29       Impact factor: 3.117

Review 2.  Leber congenital amaurosis, from darkness to light: An ode to Irene Maumenee.

Authors:  Razek Georges Coussa; Irma Lopez Solache; Robert K Koenekoop
Journal:  Ophthalmic Genet       Date:  2017-01-17       Impact factor: 1.803

Review 3.  Review and update on the molecular basis of Leber congenital amaurosis.

Authors:  Oscar Francisco Chacon-Camacho; Juan Carlos Zenteno
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

4.  Retinal findings in a patient of French ancestry with CABP4-related retinal disease.

Authors:  Vasily Mikhaïlovitch Smirnov; Christina Zeitz; Nagasamy Soumittra; Isabelle Audo; Sabine Defoort-Dhellemmes
Journal:  Doc Ophthalmol       Date:  2018-03-10       Impact factor: 2.379

5.  Viral-mediated vision rescue of a novel AIPL1 cone-rod dystrophy model.

Authors:  Cristy A Ku; Vince A Chiodo; Sanford L Boye; Abigail Hayes; Andrew F X Goldberg; William W Hauswirth; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

6.  AIPL1, A protein linked to blindness, is essential for the stability of enzymes mediating cGMP metabolism in cone photoreceptor cells.

Authors:  Saravanan Kolandaivelu; Ratnesh K Singh; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2013-10-09       Impact factor: 6.150

7.  Clinical and genetic characteristics of Leber congenital amaurosis with novel mutations in known genes based on a Chinese eastern coast Han population.

Authors:  Shiyuan Wang; Qi Zhang; Xiang Zhang; Zhaoyang Wang; Peiquan Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-16       Impact factor: 3.117

8.  Early alteration of retinal neurons in Aipl1-/- animals.

Authors:  Ratnesh Kumar Singh; Saravanan Kolandaivelu; Visvanathan Ramamurthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-15       Impact factor: 4.799

9.  Leber congenital amaurosis associated with AIPL1: challenges in ascribing disease causation, clinical findings, and implications for gene therapy.

Authors:  Mei Hong Tan; Donna S Mackay; Jill Cowing; Hoai Viet Tran; Alexander J Smith; Genevieve A Wright; Arundhati Dev-Borman; Robert H Henderson; Phillip Moradi; Isabelle Russell-Eggitt; Robert E MacLaren; Anthony G Robson; Michael E Cheetham; Dorothy A Thompson; Andrew R Webster; Michel Michaelides; Robin R Ali; Anthony T Moore
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

10.  Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.

Authors:  F M Mowat; K R Gornik; A Dinculescu; S L Boye; W W Hauswirth; S M Petersen-Jones; J T Bartoe
Journal:  Gene Ther       Date:  2013-11-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.